{
  "config": {
    "clinical_question": "Compare the effectiveness of letrozole+palbociclib with letrozole+ribociclib for the first line treatment of metastatic ER positive breast cancer.",
    "dataset_size": 1000,
    "treatment_effect_prob": 0.2,
    "target_treatment_rate": 0.5,
    "target_control_outcome_rate": 0.5,
    "enforce_positivity": false,
    "min_treatment_rate_per_stratum": 0.1,
    "max_treatment_rate_per_stratum": 0.9,
    "main_coefficient_scale": 0.3,
    "interaction_coefficient_scale": 0.1,
    "target_logit_std": 0.5,
    "num_confounders": 10,
    "outcome_type": "binary",
    "outcome_noise_std": 1.0,
    "output_dir": "./example_synthetic_data_ten_confounders",
    "llm": {
      "api_base_url": "http://localhost:8000/v1",
      "api_key": "",
      "model_name": "openai/gpt-oss-120b",
      "temperature": 0.7,
      "max_tokens": 30000,
      "timeout": 300.0
    },
    "seed": 42
  },
  "confounders": [
    {
      "name": "age",
      "type": "continuous",
      "description": "Patient age at initiation of firstâ€‘line therapy, measured in years"
    },
    {
      "name": "ecog_performance_status",
      "type": "categorical",
      "categories": [
        "0",
        "1",
        "2",
        "3"
      ],
      "description": "Eastern Cooperative Oncology Group (ECOG) performance status prior to treatment"
    },
    {
      "name": "menopausal_status",
      "type": "categorical",
      "categories": [
        "pre",
        "peri",
        "post"
      ],
      "description": "Menopausal state at baseline, which can affect endocrine therapy selection and prognosis"
    },
    {
      "name": "visceral_metastasis_pattern",
      "type": "categorical",
      "categories": [
        "bone_only",
        "liver_only",
        "lung_only",
        "multiple_visceral",
        "non_visceral"
      ],
      "description": "Pattern of metastatic involvement; presence and type of visceral disease influences drug choice and survival"
    },
    {
      "name": "prior_adjuvant_endocrine_therapy",
      "type": "categorical",
      "categories": [
        "none",
        "tamoxifen",
        "aromatase_inhibitor",
        "sequential"
      ],
      "description": "History of adjuvant endocrine therapy before metastatic recurrence, impacting resistance and physician preference"
    },
    {
      "name": "charlson_comorbidity_index",
      "type": "continuous",
      "description": "Weighted score summarizing baseline comorbid conditions; higher scores predict poorer outcomes and may limit CDK4/6 inhibitor use"
    },
    {
      "name": "baseline_neutrophil_to_lymphocyte_ratio",
      "type": "continuous",
      "description": "Inflammatory marker calculated from the complete blood count; associated with both prognosis and treatment tolerance"
    },
    {
      "name": "insurance_type",
      "type": "categorical",
      "categories": [
        "private",
        "medicare",
        "medicaid",
        "uninsured"
      ],
      "description": "Primary payer source, influencing access to specific CDK4/6 inhibitors and overall care"
    },
    {
      "name": "baseline_serum_albumin",
      "type": "continuous",
      "description": "Serum albumin level (g/dL) at treatment start, reflecting nutritional status and linked to survival"
    },
    {
      "name": "geographic_region",
      "type": "categorical",
      "categories": [
        "northeast",
        "midwest",
        "south",
        "west"
      ],
      "description": "U.S. Census region where care is delivered; captures regional prescribing patterns and resource availability"
    }
  ],
  "treatment_equation": {
    "intercept": -0.10756558920873147,
    "coefficients": {
      "age": -0.11550742838630107,
      "charlson_comorbidity_index": -0.1732611425794516,
      "baseline_neutrophil_to_lymphocyte_ratio": -0.057753714193150535,
      "baseline_serum_albumin": 0.23101485677260214,
      "ecog_performance_status_1": -0.23101485677260214,
      "ecog_performance_status_2": -0.5775371419315054,
      "ecog_performance_status_3": -0.9240594270904086,
      "menopausal_status_peri": 0.0,
      "menopausal_status_post": 0.11550742838630107,
      "visceral_metastasis_pattern_liver_only": 0.3465222851589032,
      "visceral_metastasis_pattern_lung_only": 0.23101485677260214,
      "visceral_metastasis_pattern_multiple_visceral": 0.4620297135452043,
      "visceral_metastasis_pattern_non_visceral": 0.11550742838630107,
      "prior_adjuvant_endocrine_therapy_tamoxifen": 0.23101485677260214,
      "prior_adjuvant_endocrine_therapy_aromatase_inhibitor": 0.11550742838630107,
      "prior_adjuvant_endocrine_therapy_sequential": 0.3465222851589032,
      "insurance_type_medicare": 0.0,
      "insurance_type_medicaid": -0.23101485677260214,
      "insurance_type_uninsured": -0.5775371419315054,
      "geographic_region_midwest": 0.11550742838630107,
      "geographic_region_south": 0.057753714193150535,
      "geographic_region_west": -0.057753714193150535
    },
    "interactions": [
      {
        "terms": [
          "age",
          "charlson_comorbidity_index"
        ],
        "coefficient": -0.019251238064383516
      },
      {
        "terms": [
          "insurance_type_medicare",
          "geographic_region_west"
        ],
        "coefficient": -0.026951733290136923
      }
    ],
    "original_intercept": -0.2
  },
  "outcome_equation": {
    "intercept": 0.46073440180247827,
    "coefficients": {
      "age": -0.15343894875436992,
      "charlson_comorbidity_index": -0.1278657906286416,
      "baseline_neutrophil_to_lymphocyte_ratio": -0.07671947437718496,
      "baseline_serum_albumin": 0.15343894875436992,
      "ecog_performance_status_1": -0.20458526500582655,
      "ecog_performance_status_2": -0.4091705300116531,
      "ecog_performance_status_3": -0.6137557950174797,
      "menopausal_status_peri": 0.05114631625145664,
      "menopausal_status_post": 0.10229263250291327,
      "visceral_metastasis_pattern_liver_only": -0.30687789750873984,
      "visceral_metastasis_pattern_lung_only": -0.2557315812572832,
      "visceral_metastasis_pattern_multiple_visceral": -0.46031684626310976,
      "visceral_metastasis_pattern_non_visceral": -0.10229263250291327,
      "prior_adjuvant_endocrine_therapy_tamoxifen": -0.05114631625145664,
      "prior_adjuvant_endocrine_therapy_aromatase_inhibitor": -0.02557315812572832,
      "prior_adjuvant_endocrine_therapy_sequential": -0.10229263250291327,
      "insurance_type_medicare": -0.02557315812572832,
      "insurance_type_medicaid": -0.10229263250291327,
      "insurance_type_uninsured": -0.20458526500582655,
      "geographic_region_midwest": 0.02557315812572832,
      "geographic_region_south": 0.010229263250291328,
      "geographic_region_west": -0.01534389487543699
    },
    "interactions": [
      {
        "terms": [
          "age",
          "baseline_serum_albumin"
        ],
        "coefficient": -0.017048772083818883
      },
      {
        "terms": [
          "visceral_metastasis_pattern_multiple_visceral",
          "charlson_comorbidity_index"
        ],
        "coefficient": -0.034097544167637765
      }
    ],
    "treatment_coefficient": 0.2,
    "treatment_interactions": [
      {
        "term": "age",
        "coefficient": -0.04277873838868641
      },
      {
        "term": "ecog_performance_status_1",
        "coefficient": 0.15368250969798336
      },
      {
        "term": "ecog_performance_status_2",
        "coefficient": 0.07910423677538769
      },
      {
        "term": "ecog_performance_status_3",
        "coefficient": 0.033640120224206475
      },
      {
        "term": "menopausal_status_peri",
        "coefficient": -0.11728919600358106
      },
      {
        "term": "menopausal_status_post",
        "coefficient": -0.11729742036745744
      },
      {
        "term": "visceral_metastasis_pattern_liver_only",
        "coefficient": -0.15068263552497757
      },
      {
        "term": "visceral_metastasis_pattern_lung_only",
        "coefficient": 0.12485707303696215
      },
      {
        "term": "visceral_metastasis_pattern_multiple_visceral",
        "coefficient": 0.03447773578925273
      },
      {
        "term": "visceral_metastasis_pattern_non_visceral",
        "coefficient": 0.07094763911474905
      },
      {
        "term": "prior_adjuvant_endocrine_therapy_tamoxifen",
        "coefficient": -0.1634689138039927
      },
      {
        "term": "prior_adjuvant_endocrine_therapy_aromatase_inhibitor",
        "coefficient": 0.1602277193890173
      },
      {
        "term": "prior_adjuvant_endocrine_therapy_sequential",
        "coefficient": 0.11335477627898516
      },
      {
        "term": "charlson_comorbidity_index",
        "coefficient": -0.09808529878949436
      },
      {
        "term": "baseline_neutrophil_to_lymphocyte_ratio",
        "coefficient": -0.1084898723369548
      },
      {
        "term": "insurance_type_medicare",
        "coefficient": -0.10795128708547465
      },
      {
        "term": "insurance_type_medicaid",
        "coefficient": -0.06674858766844864
      },
      {
        "term": "insurance_type_uninsured",
        "coefficient": 0.008441335210133344
      },
      {
        "term": "baseline_serum_albumin",
        "coefficient": -0.02320507732678222
      },
      {
        "term": "geographic_region_midwest",
        "coefficient": -0.07118573613012977
      },
      {
        "term": "geographic_region_south",
        "coefficient": 0.038139090180744704
      },
      {
        "term": "geographic_region_west",
        "coefficient": -0.12292374009121577
      }
    ],
    "original_intercept": -1.2
  },
  "summary_statistics": {
    "age": {
      "type": "continuous",
      "mean": 64.2,
      "std": 11.3
    },
    "ecog_performance_status": {
      "type": "categorical",
      "proportions": {
        "0": 0.22,
        "1": 0.46,
        "2": 0.22,
        "3": 0.1
      }
    },
    "menopausal_status": {
      "type": "categorical",
      "proportions": {
        "pre": 0.14,
        "peri": 0.11,
        "post": 0.75
      }
    },
    "visceral_metastasis_pattern": {
      "type": "categorical",
      "proportions": {
        "bone_only": 0.3,
        "liver_only": 0.2,
        "lung_only": 0.1,
        "multiple_visceral": 0.25,
        "non_visceral": 0.15
      }
    },
    "prior_adjuvant_endocrine_therapy": {
      "type": "categorical",
      "proportions": {
        "none": 0.2,
        "tamoxifen": 0.3,
        "aromatase_inhibitor": 0.35,
        "sequential": 0.15
      }
    },
    "charlson_comorbidity_index": {
      "type": "continuous",
      "mean": 4.1,
      "std": 2.4
    },
    "baseline_neutrophil_to_lymphocyte_ratio": {
      "type": "continuous",
      "mean": 3.2,
      "std": 1.6
    },
    "insurance_type": {
      "type": "categorical",
      "proportions": {
        "private": 0.35,
        "medicare": 0.45,
        "medicaid": 0.15,
        "uninsured": 0.05
      }
    },
    "baseline_serum_albumin": {
      "type": "continuous",
      "mean": 3.9,
      "std": 0.5
    },
    "geographic_region": {
      "type": "categorical",
      "proportions": {
        "northeast": 0.2,
        "midwest": 0.2,
        "south": 0.35,
        "west": 0.25
      }
    }
  },
  "dataset_statistics": {
    "n_patients": 1000,
    "treatment_rate": 0.501,
    "outcome_rate": 0.503,
    "mean_treatment_prob": 0.4997919037901713,
    "std_treatment_prob": 0.12030561781452126,
    "mean_outcome_prob": 0.5156668278912037,
    "std_outcome_prob": 0.10889003886528639,
    "mean_ite_prob": 0.031373963349506796,
    "std_ite_prob": 0.059035543128549695,
    "clinical_text_stats": {
      "non_empty_count": "1000",
      "mean_length": 9069.518
    }
  }
}